Tracon Pharmaceuticals Inc Expected To Post A Loss Of 32 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

02/11/2021 02:09

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 3. 
* The San Diego, California-based company is expected to report
revenue of $57.14 thousand, according to the mean estimate from
7 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for TRACON Pharmaceuticals
Inc is for a loss of 32 cents per share. For the same quarter
last year, the company reported a loss of 38 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $11​, about 65.8% above​ its last closing
price of $3.76. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.32       -0.31      -0.58     Missed  -86.2
 Mar. 312021   -0.30       -0.30      -0.33     Missed  -8.2
 Dec. 312020   -0.44       -0.41      -0.31     Beat    23.6​
 Sep. 302020   -0.64       -0.65      -0.38     Beat    41.5
 ​​Jun.        -0.73       -0.73      -0.70     Beat    3.7
 302020                                                 
 Mar. 312020   -1.12       -1.13      -0.78     Beat    31.1​
 Dec. 312019   -1.65       -1.66      -1.25     Beat    24.9
 Sep. 302019   -2.07       -2.05      -1.70     Beat    17.1
 This summary was machine generated November 2 at 02:08 GMT.  All
figures in US dollars unless otherwise stated